COVID-19-Related Death Up for Adults With Down Syndrome
Ashley Kieran Clift, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues examined Down syndrome as a risk factor for death from COVID-19 through an analysis of data from 8.26 million adults during Jan. 24 to June 30, 2020.
The researchers found that 4,053 of the adults in the study cohort had Down syndrome. Of those with Down syndrome, 68 persons died: 39.7, 25.0, and 35.3 percent of COVID-19, pneumonia or pneumonitis, and other causes, respectively. Of the 8,252,105 persons without Down syndrome, 41,685 died: 20.3, 14.4, and 65.3 percent of COVID-19, pneumonia or pneumonitis, and other causes, respectively. The hazard ratio for COVID-19-related death in adults with versus without Down syndrome was 24.94 after adjustment for age and sex. After further adjustment for ethnicity, body mass index, dementia diagnosis, care home residency, and a range of comorbid conditions and treatments, the hazard ratios for COVID-19-related death and hospitalization were 10.39 and 4.94, respectively.
"We are unaware of the effects of Down syndrome on COVID-19 outcomes being reported elsewhere yet during this pandemic," the authors write. "Novel evidence that specific conditions may confer elevated risk should be used by public health organizations, policymakers, and health care workers to strategically protect vulnerable individuals."
Several authors disclosed financial ties to the medical technology industry.
© 2020 HealthDay. All rights reserved.
Posted: October 2020
Further Support and Information on COVID-19
Read this next
MONDAY, Nov. 23, 2020 -- Fresh takes on the efficacy of fish oil and vitamin D, new treatments for heart failure patients, the cardiovascular effects of COVID-19, and structural...
MONDAY, Nov. 23, 2020 -- A combination of two monoclonal antibodies was granted emergency use authorization (EUA) for the treatment of mild-to-moderate COVID-19, the U.S. Food and...
MONDAY, Nov. 23, 2020 -- Due to disproportionate representation, Black and Hispanic patients bear much of the burden of mortality and morbidity related to COVID-19, according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.